NASDAQ:CRON

Cronos Group Stock Forecast, Price & News

$7.29

+0.14 (+1.96 %)

(As of 07/26/2021 12:00 AM ET)

Add

Compare

Today's Range

$7.05

▼

$7.38

50-Day Range

$7.15

▼

$9.06

52-Week Range

$4.91

▼

$15.83

Volume1.32 million shs

Average Volume4.21 million shs

Market Capitalization$2.71 billion

P/E RatioN/A

Dividend YieldN/A

Beta1.78

30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

About Cronos Group

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

How to Find an Income-Driven Stock With Strong Dividends
July 22, 2021 | msn.com

Stocks Limp into Weekend
July 16, 2021 | ca.finance.yahoo.com

Zacks: Analysts Anticipate Cronos Group Inc. (NASDAQ:CRON) Will Announce Earnings of -$0.07 Per Share
July 15, 2021 | americanbankingnews.com

Canadian Market Modestly Lower; Energy, Healthcare Stocks Lose Ground
July 15, 2021 | markets.businessinsider.com

Cronos Group (NASDAQ:CRON) Trading 4.7% Higher
July 13, 2021 | americanbankingnews.com

Unusual Options Activity Insight: Cronos Group
July 7, 2021 | msn.com

TSX Keeps Win Streak Rolling
June 24, 2021 | baystreet.ca

Cronos Group Inc.: Cronos Now Offers Investors U.S. THC Exposure by Acquiring Option for 10.5% of U.S. MSO PharmaCann
June 14, 2021 | finance.yahoo.com

Cronos Group Shares Slightly Up After Announcing Purchase Of 10.5% Stake In PharmaCann For $110.4M
June 14, 2021 | msn.com

Canadian Marijuana Companies Make More Inroads In U.S. Market
June 14, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CRON
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.thecronosgroup.com
Phone416-504-0004
Employees631
Year FoundedN/A

Sales & Book Value

Annual Sales$46.72 million
Price / Sales58.02
Cash FlowN/A
Price / Cash FlowN/A
Book Value$4.74 per share
Price / Book1.54

Profitability

EPS (Most Recent Fiscal Year)($0.38)
Net Income$-73,140,000.00
Net Margins-610.02%
Return on Equity-11.39%
Return on Assets-10.00%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares371,806,000
Market Cap$2.71 billion
Next Earnings Date8/6/2021 (Confirmed)
OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.95 out of 5 stars

Medical Sector

2403rd out of 4,434 stocks

Medicinals & Botanicals Industry

17th out of 74 stocks

1.8 Analyst's Opinion

Consensus Rating
Cronos Group has received a consensus rating of Hold. The company's average rating score is 1.67, and is based on 1 buy rating, 2 hold ratings, and 3 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $8.80, Cronos Group has a forecasted upside of 20.7% from its current price of $7.29.
Amount of Analyst Coverage
Cronos Group has only been the subject of 2 research reports in the past 90 days.

2.3 Community Rank

Outperform Votes
Cronos Group has received 445 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cronos Group has received 524 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cronos Group has received 54.08% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote “Outperform” if you believe CRON will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cronos Group does not currently pay a dividend.
Dividend Growth
Cronos Group does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cronos Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 5.52% of the stock of Cronos Group is held by insiders.
Percentage Held by Institutions
Only 13.00% of the stock of Cronos Group is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Cronos Group are expected to grow in the coming year, from ($0.29) to ($0.21) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cronos Group is -8.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cronos Group is -8.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cronos Group has a P/B Ratio of 1.54. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Cronos Group (NASDAQ:CRON) Frequently Asked Questions

Is Cronos Group a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Cronos Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View analyst ratings for Cronos Group or view top-rated stocks.

What stocks does MarketBeat like better than Cronos Group?

Wall Street analysts have given Cronos Group a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cronos Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for Cronos Group.

How can I listen to Cronos Group's earnings call?

Cronos Group will be holding an earnings conference call on Friday, August 6th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) released its earnings results on Thursday, May, 6th. The company reported ($0.44) earnings per share for the quarter, missing the consensus estimate of ($0.09) by $0.35. The company had revenue of $14.60 million for the quarter, compared to analyst estimates of $22.19 million. Cronos Group had a negative net margin of 610.02% and a negative trailing twelve-month return on equity of 11.39%. The firm's quarterly revenue was up 57.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.20 earnings per share.
View Cronos Group's earnings history.

How has Cronos Group's stock been impacted by Coronavirus?

Cronos Group's stock was trading at $5.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CRON shares have increased by 34.8% and is now trading at $7.29.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for CRON?

6 brokerages have issued 1 year price targets for Cronos Group's stock. Their forecasts range from $5.00 to $12.50. On average, they anticipate Cronos Group's share price to reach $8.80 in the next twelve months. This suggests a possible upside of 20.7% from the stock's current price.
View analysts' price targets for Cronos Group or view top-rated stocks among Wall Street analysts.

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:

Mr. Michael Ryan Gorenstein, Exec. Chairman (Age 34, Pay $493.54k)
Mr. Kurt Thomas Schmidt B.Sc., M.B.A., Pres & CEO (Age 64, Pay $389.62k)
Mr. Jerry Filomena Barbato, Chief Financial Officer (Age 45, Pay $249.24k)
Ms. Xiuming Shum, Exec. VP of Legal and Regulatory Affairs & Corp. Sec. (Age 35, Pay $474.88k)
Ms. Anna Shlimak, Sr. VP of Corp. Affairs (Age 35, Pay $623.3k)
Dr. Todd K. Abraham, Chief Innovation Officer (Age 66, Pay $488.69k)
Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
Ms. Shannon Buggy, Sr. VP & Global Head of People (Age 51)
Mr. Jeffrey David Jacobson, Gen. Mang. of Canada & Europe (Age 35)
Ms. Summer Frein, Gen. Mang. of USA (Age 37)

Who are some of Cronos Group's key competitors?

Some companies that are related to Cronos Group include Canopy Growth (CGC), STADA Arzneimittel Aktiengesellschaft (STDAF), Tilray (TLRY), USANA Health Sciences (USNA), Aurora Cannabis (ACB), Sundial Growers (SNDL), True Drinks (TRUU), ChromaDex (CDXC), HEXO (HEXO), Canopy Rivers (RIV), Natural Alternatives International (NAII), MediWound (MDWD), Bon Natural Life (BON), Grove (GRVI) and Mannatech (MTEX).
View all of CRON's competitors.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC), Aurora Cannabis (ACB), Tilray (TLRY), (APHA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $7.29.

How much money does Cronos Group make?

Cronos Group has a market capitalization of $2.71 billion and generates $46.72 million in revenue each year. The company earns $-73,140,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis.

How many employees does Cronos Group have?

Cronos Group employs 631 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

Where are Cronos Group's headquarters?

Cronos Group is headquartered at 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9.

How can I contact Cronos Group?

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The company can be reached via phone at 416-504-0004.

This page was last updated on 7/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here